Best Alzheimer's and Dementia Research Grants in Georgia

ISTAART Professional Interest Area executive committee members worldwide can request up to US $20,000 to organize dementia and Alzheimer’s research conferences, workshops, or convenings through this program. Georgia-based dementia researchers engaged in ISTAART PIAs may be eligible to support training, networking, and knowledge-sharing events that advance the field.

BrightFocus Foundation offers Alzheimer's Disease Research Grants to support innovative research aimed at understanding, preventing, and treating Alzheimer's disease. These grants encourage applications from diverse backgrounds, fostering creativity in scientific research. The program includes Standard Awards for early investigators with a maximum funding of $300,000 for three years and Postdoctoral Fellowship Awards for young researchers at $200,000 for two years, promoting the development of independent research careers.

The JTMF Foundation Grant focuses on improving the lives of individuals in need, particularly in the Pacific Northwest. By partnering with organizations addressing immediate needs and long-term challenges, the foundation supports children, older adults, veterans, and individuals with intellectual and developmental disabilities. Guided by Catholic values, JTMF aims to empower communities while seeking innovative solutions to societal issues. Organizations that align with these focus areas are encouraged to connect, fostering a collaborative effort towards meaningful impact.

Georgia nonprofit member organizations of the Alzheimer’s Foundation of America that run programs for people affected by Alzheimer’s or related dementias can access this bi-annual grant. Funding of US $6,000 can support new or existing services, including administrative costs, staff salaries and training, occupancy, and necessary supplies or equipment.

Universities, research institutions, and medical centers in Georgia working on Alzheimer’s and related dementias can access funding through the National Institutes of Health to run postbaccalaureate research education programs, with awards up to US $400,000. These one-to-two-year programs provide intensive AD/ADRD research experience, mentorship, and professional development for recent graduates across U.S. states and territories.

Nonprofit and academic organizations offering Alzheimer’s and dementia-focused summer research education in Georgia can apply for up to US $200,000 to run hands-on programs for high school students, undergraduates, or science teachers. With a mission to advance dementia and STEM research, the National Institutes of Health supports authentic lab experiences and complementary educational enrichment activities.

Georgia dementia and Alzheimer’s disease researchers can access funding through the Alzheimer’s Association AARGA program, which supports early-career investigators developing pilot or preliminary data. U.S. and international assistant professors (or equivalent, within seven years) may receive US $70,000 - US $200,000 for basic, translational, clinical, psychosocial, or related dementia research projects.

Georgia nonprofits with 501(c)(3) status working on dementia and brain degenerative disease care can access funding through Sephardic Home For The Aged Foundation to improve support and quality of life for older adults. Eligible organizations must be at least two years old and may propose innovative aging-related programs or services.

Postdoctoral researchers conducting Alzheimer’s and dementia research in Georgia can seek funding for early-career projects through the Alzheimer’s Association Research Fellowship for All, with awards up to US $200,000. Grants from the Alzheimer’s Association support mentored research that helps investigators transition toward independent careers in Alzheimer’s and related dementias, encouraging applicants from underrepresented groups.

Clinician scientists conducting dementia and Alzheimer’s disease research in Georgia can access funding through the Alzheimer’s Association, with awards up to US $250,000. Licensed, practicing clinicians in patient-facing or diagnostic fields may be eligible, and individuals from underrepresented groups are especially encouraged to apply for this fellowship support.

With a mission to support individuals and families affected by dementia, Alzheimer’s Foundation of America provides Georgia Alzheimer’s-focused nonprofits with US $25,000 for innovative programs improving quality of life. Only AFA nonprofit member organizations may apply, and funds can cover program-related staff, training, occupancy, supplies, equipment, and other eligible administrative costs.

Public safety agencies in Georgia that belong to both the Alzheimer’s Foundation of America and Project Lifesaver International can seek funding for dementia-related wandering prevention and public safety initiatives. Focused on dementia and Alzheimer’s disease, the Alzheimer’s Foundation of America invites eligible agencies to apply for US $6,000 to support training, equipment, administration, and community outreach.

Nonprofit organizations providing Alzheimer’s respite care services in Georgia can apply for Alzheimer’s Foundation of America’s Milton & Phyllis Berg Family Respite Care Grants; awards US $6,000 for respite care scholarships and related program costs. Funding may cover supplies, equipment, capacity building, administrative expenses, and staff training to better support dementia-affected families.

Georgia research institutions and medical centers conducting imaging research on Alzheimer’s and other neurodegenerative diseases can access funding through the Alzheimer’s Association and the American Society of Neuroradiology. Grants from Alzheimer’s Association help Georgia dementia and Alzheimer’s disease researchers pursue early-stage pilot projects, novel imaging tools, and innovative imaging data analysis, with awards of US $200,000.

Georgia Alzheimer’s and dementia researchers studying olfactory decline in aging or Alzheimer’s disease and related dementias can access funding via the National Institutes of Health. Focused on mechanisms linking smell loss with aging and AD/ADRD, this upcoming R01 NOFO will support cellular, molecular, imaging, physiological, omics, and related mechanistic studies in older adults and animal models.

Academic and research institutions studying dementia and Alzheimer’s disease can apply for National Institute on Aging R01 funding to investigate cerebellar roles in cognition and emotion across aging and Alzheimer’s/ADRD. Focus areas include basic and animal studies, secondary data analyses, and intervention-targeting research; Georgia-based Alzheimer’s and dementia researchers may be eligible within this national opportunity.

Families needing in-home respite care for loved ones with Alzheimer’s or other dementias in the Boyertown Area School District can apply for the Margaret B. Moeller Memorial Fund, awarding US $200 - US $3,000 for companion or aide services. Georgia organizations serving such families may note this as a model but are not the direct applicants.

Georgia Alzheimer’s and dementia researchers can access funding through the National Institutes of Health for preclinical validation and early-stage drug discovery targeting novel mechanisms in AD and related dementias. This upcoming U01 opportunity from the National Institute on Aging supports rigorous work on small molecules, biologics, and emerging therapeutic modalities across the U.S. territories and states.

Research institutions and interdisciplinary consortia studying mechanisms of neurodegeneration in Alzheimer’s disease-related dementias can apply for National Institutes of Health support, including teams in Georgia. The NINDS Centers without Walls program funds collaborative networks using advanced technologies, disease-relevant models, clinical science, and human specimens to uncover ADRD mechanisms, therapeutic targets, and biomarkers.

Research institutions and investigative teams studying how neural exposome factors affect Alzheimer’s disease-related dementias can apply for National Institutes of Health support, including work in Georgia. This NIH opportunity funds mechanistic, translational, and human subjects research on environmental toxins, sleep, stress, and related pathways influencing ADRD pathology, progression, resilience, and neurological health disparities.

Research institutions and qualified organizations studying Alzheimer’s and dementia can apply for National Institutes of Health phased grants supporting functional validation of new therapeutic targets, including work in Georgia. Funding supports technology development, disease models, and cross-lab validation to de-risk translational research, though applications are not being accepted yet as this is an advance notice.

Research institutions and eligible organizations in Georgia studying dementia and Alzheimer’s care pathways and early detection can apply for the Alzheimer’s Association’s Health Services Research in Alzheimer’s Disease and Related Disorders program, with awards up to US $250,000. Funding supports rigorous health services research on detection, diagnosis, and post-diagnostic care for cognitive impairment, including MCI and AD/ADRD.

The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.

The DoW Alzheimer’s Transforming Research Award supports innovative research aimed at reducing the risk and preventing Alzheimer’s disease and related dementias. It emphasizes projects that enhance understanding of risk factors and develop effective risk reduction strategies. Clinical research is permitted, but trials and animal studies are not. Collaboration and preliminary data are essential for proposal consideration, and an option for multiple principal investigators is available to foster partnerships.

The FY26 Alzheimer’s Research Program's Transforming Diagnosis Award (TrDA) promotes innovative research aimed at overcoming significant barriers to accurate diagnosis and monitoring of Alzheimer's disease. This award encourages community collaboration and requires preliminary data. It supports studies leveraging existing cohorts, especially those including individuals aged 65 and younger. The TrDA also offers a partnership option for multiple principal investigators, fostering collaborative research efforts while ensuring at least one independent investigator meets eligibility criteria.

The DoW Alzheimer’s Transforming Care Award aims to support innovative clinical research and trials enhancing dementia care for individuals with Alzheimer’s disease. This funding opportunity encourages collaborative partnerships and requires preliminary data, focusing on interventions that do not solely test pharmacological solutions. Community collaboration is essential, and studies leveraging existing cohorts, including those with younger participants, are encouraged. The award supports both new and existing partnerships among principal investigators.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) aims to create a secure, scalable cloud platform for genetic data related to Alzheimer’s disease. This initiative will enhance data accessibility, promote interoperability, and support rigorous research practices. By facilitating collaboration and providing robust analytical tools, the platform will maximize the scientific impact of AD/ADRD research, aligning with NIH goals for transparent and reproducible science, while addressing recommendations for broad access to high-value datasets.